'Conjugate vaccines' presentation slideshows

Conjugate vaccines - PowerPoint PPT Presentation

Meningococcal Vaccines The Journey Continues

Meningococcal Vaccines The Journey Continues

Meningococcal Vaccines The Journey Continues. Canadian Public Health Association Conference June 19, 2011. Bryna Warshawsky, Associate Medical Officer of Health 519-663-5317 ext. 2427; bryna.warshawsky@mlhu.on.ca. Outline. Background Epidemiology Journey Polysaccharide vaccines

★ ★ ★ ★ ★

650 views • 48 slides
WHO Technical Specifications and Pre-Qualification

WHO Technical Specifications and Pre-Qualification

WHO Technical Specifications and Pre-Qualification. UNICEF Vaccine Pre-Tender 2010-2012 Copenhagen Denmark 10 December 2008. Dr. Nora Dellepiane, Scientist WHO/IVB/QSS Carmen Rodriguez, Scientist WHO/IVB/QSS 10 December 2008. Outline of presentation. Introduction

★ ★ ★ ★ ★

365 views • 36 slides
Immunoprophylaxis (prophylactic immunization)

Immunoprophylaxis (prophylactic immunization)

Immunoprophylaxis (prophylactic immunization). Immunoprophylaxis. Types of immunization Immunoglobulins and vaccines Strategies in vaccine preparation Mechanisms of action of different types of vaccines. NATURAL. Transplacental transfer of IgG Immunoglobulines in milk

★ ★ ★ ★ ★

1.7k views • 26 slides
Evidence and control: meningococcal disease

Evidence and control: meningococcal disease

Evidence and control: meningococcal disease. Public health policy in UK. Cases and contacts bp to case before admission rif or cipro to case and close contacts vaccinate close contacts if A,C,W135,Y give out information

★ ★ ★ ★ ★

300 views • 19 slides
EPIDEMIOLOGICAL INVESTIGATION OF S.PNEUMONIAE INVASIVE INFECTIONS IN ARGENTINIAN CHILDREN

EPIDEMIOLOGICAL INVESTIGATION OF S.PNEUMONIAE INVASIVE INFECTIONS IN ARGENTINIAN CHILDREN

EPIDEMIOLOGICAL INVESTIGATION OF S.PNEUMONIAE INVASIVE INFECTIONS IN ARGENTINIAN CHILDREN. PARTICIPANT INSTITUTIONS HOSPITAL CITY. SOR LUDOVICA CHILDREN HOSPITAL LA PLATA P. GARRAHAM CHILDREN HOSPITAL B. AIRES

★ ★ ★ ★ ★

332 views • 19 slides
Haemophilus influenzae type B and Hib Vaccine

Haemophilus influenzae type B and Hib Vaccine

Haemophilus influenzae type B and Hib Vaccine. Dr Seyed Mohsen Zahraei Center for Communicable Disease Control. Haemophilus influenzae type b Epidemiology. Reservoir Human Asymptomatic carriers Transmission Respiratory droplets Temporal pattern Peaks in Sept-Dec and

★ ★ ★ ★ ★

205 views • 18 slides
Note to presenters:

Note to presenters:

Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at http://www.vaccineinformation.org/photos/index.asp. Haemophilus influenzae type b Clinical Features*. *prevaccination era. Incidence* of Invasive Hib Disease, 1980-2009.

★ ★ ★ ★ ★

243 views • 13 slides
Note to presenters:

Note to presenters:

Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at http://www.vaccineinformation.org/photos/index.asp. Haemophilus influenzae type b Clinical Features*. *prevaccination era. Incidence* of Invasive Hib Disease, 1980-2009.

★ ★ ★ ★ ★

136 views • 13 slides
Global Conjugate Vaccine Market Research and Forecast, 2018-2023

Global Conjugate Vaccine Market Research and Forecast, 2018-2023

Global Conjugate Vaccine Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

★ ★ ★ ★ ★

131 views • 12 slides
Vaccines Market worth 48.03 Billion USD by 2021 - Market Dynamics - Key Players Strategies

Vaccines Market worth 48.03 Billion USD by 2021 - Market Dynamics - Key Players Strategies

The global vaccines market is expected to reach 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3%. The global market is broadly classified into technology, type, disease indication, end-users, and regions.

★ ★ ★ ★ ★

300 views • 7 slides
Vaccines Market by Technology, Disease Indication, End User & Type - 2021 | MarketsandMarkets

Vaccines Market by Technology, Disease Indication, End User & Type - 2021 | MarketsandMarkets

The global vaccines market is expected to reach 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3%. The global market is broadly classified into technology, type, disease indication, end-users, and regions.

★ ★ ★ ★ ★

191 views • 7 slides
Conjugate Vaccine Market - Predicted to Rise at a Lucrative CAGR throughout 2017 to 2025

Conjugate Vaccine Market - Predicted to Rise at a Lucrative CAGR throughout 2017 to 2025

The global conjugate vaccine market can be classified on the basis of product type, disease indication, pathogen type, patient type, and region. In terms of product type, the global conjugate vaccine market can be segmented into multivalent conjugate vaccines and monovalent conjugate vaccines.

★ ★ ★ ★ ★

81 views • 5 slides
global conjugates vaccine market is expected to grow at a CAGR of 10.5% during the forecast period 2017-2023

global conjugates vaccine market is expected to grow at a CAGR of 10.5% during the forecast period 2017-2023

Conjugate vaccines are vaccines for infectious diseases. There are special polysaccharide coatings on some bacteria and viruses that help them to escape the immune system

★ ★ ★ ★ ★

44 views • 4 slides
Conjugate Vaccine Market

Conjugate Vaccine Market

Conjugate Vaccine Market Research Report - Global Forecast till 2023

★ ★ ★ ★ ★

46 views • 4 slides
Vaccine Conjugates Market 2018 Booming Healthcare Industry by 14.5 % CAGR till 2027 with Most Demanding Players

Vaccine Conjugates Market 2018 Booming Healthcare Industry by 14.5 % CAGR till 2027 with Most Demanding Players

Market Research Future has declared the expansion of the "Worldwide Vaccine Conjugates Market Research Report which gives Market Size, Shares and Forecasts till 2027.

★ ★ ★ ★ ★

33 views • 3 slides
Carbohydrate Conjugate Vaccine

Carbohydrate Conjugate Vaccine

Carbohydrate Conjugate VaccineCarbohydrate Conjugate VaccineCarbohydrate Conjugate VaccineCarbohydrate Conjugate VaccineCarbohydrate Conjugate Vaccine

★ ★ ★ ★ ★

32 views • 3 slides
an introduction for Carrier Protein Design

an introduction for Carrier Protein Design

an introduction for Carrier Protein Designan introduction for Carrier Protein Designan introduction for Carrier Protein Designan introduction for Carrier Protein Designan introduction for Carrier Protein Designan introduction for Carrier Protein Design

★ ★ ★ ★ ★

36 views • 3 slides
Conjugate Vaccine Market Industry Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast 2019 to 2

Conjugate Vaccine Market Industry Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast 2019 to 2

Conjugate Vaccine Market by Product Type (Multivalent Conjugate Vaccines, Monovalent Conjugate Vaccines), by Disease (Meningococcal, Diphtheria Tetanus Pertussis, Influenza, Pneumococcal), by Patient Type (Adults, Children), by Pathogen Type (Combination Vaccine, Bacterial Conjugate Vaccine, Viral Conjugate Vaccine) - Global Trends, Market Size, Share, Research and Forecast 2019-2025

★ ★ ★ ★ ★

33 views • 3 slides
Conjugation Method Design

Conjugation Method Design

an introduction for Conjugation Method Designan introduction for Conjugation Method Designan introduction for Conjugation Method Designvan introduction for Conjugation Method Design

★ ★ ★ ★ ★

20 views • 2 slides

View Conjugate vaccines PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Conjugate vaccines PowerPoint presentations. You can view or download Conjugate vaccines presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.